Literature DB >> 3109443

Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells.

T Leizer, B J Clarris, P E Ash, J van Damme, J Saklatvala, J A Hamilton.   

Abstract

Monocyte-macrophage polypeptides (monokines) cause synovial cells to increase the levels of putative mediators of destruction and inflammation. This interaction may account for some of the properties of rheumatoid pannus. We report here that samples of purified human interleukin-1 beta (IL-1 beta) and recombinant IL-1 alpha stimulate both the plasminogen activator activity and prostaglandin E2 levels of human synovial fibroblast-like cells. The same holds true for purified pig IL-1 (catabolin) and recombinant murine IL-1. The elevation in plasminogen activator activity was inhibited by indomethacin, and this suggests that endogenous prostanoids are important in the IL-1-mediated stimulation of proteinase activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109443     DOI: 10.1002/art.1780300511

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

1.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

2.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

3.  Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells.

Authors:  A C Kohl; D N Tatakis; C Hansen; R Dziak
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

Review 4.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

Review 5.  Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

Authors:  Z Szekanecz; A E Koch; S L Kunkel; R M Strieter
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

6.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.

Authors:  M B Goldring; J Birkhead; L J Sandell; T Kimura; S M Krane
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid.

Authors:  A Bendrups; A Hilton; A Meager; J A Hamilton
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Authors:  Andrew D Cook; Christine M De Nardo; Emma L Braine; Amanda L Turner; Ross Vlahos; Kerrie J Way; S Kaye Beckman; Jason C Lenzo; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

9.  Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

Authors:  J A Hamilton; D S Piccoli; T Leizer; D M Butler; M Croatto; A K Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

10.  Effects of interleukin-1 on syntheses of alkaline phosphatase, type X collagen, and 1,25-dihydroxyvitamin D3 receptor, and matrix calcification in rabbit chondrocyte cultures.

Authors:  Y Kato; K Nakashima; M Iwamoto; H Murakami; H Hiranuma; T Koike; F Suzuki; H Fuchihata; Y Ikehara; M Noshiro
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.